Supporting patients during pregnancy and beyond
Podcast content: This podcast is available to listen to online.
Listen to podcast online (https://www.buzzsprout.com/2241774/18062564)
Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy and after one year after pregnancy. This represents
roughly one in 3,000 pregnancies.
In a recent episode of Cleveland Clinic's Cancer Advances podcast, Erin Roesch, MD, Breast Medical Oncologist discussed:
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Click the podcast player above to listen to the episode now.
Podcast host Dr. Shepard: I'm guessing that managing the complexity of having a breast cancer, coupled with pregnancy, must take a big team. We're going to talk about multidisciplinary care. What does that look like?
Dr. Roesch: Multidisciplinary are includes multiple team members - medical oncologists, breast surgeons, radiation oncologists, genetic counselors, social workers, psychologists, obstetricians, gynecologists and sometimes reproductive providers.
Dr. Shepard: Are there things over time we've learned to do really well?
Where do we need to make improvements?
Dr. Roesch: In terms of some of the psychosocial aspects, we're striving to make improvements and gain a better understanding of the needs of this
population beyond chemotherapy, radiation, and surgery.
It's about having a better understanding of this patient population. Many of these patients may be interested in future pregnancies, so engaging
reproductive endocrinology early on to discuss oncogertility, providing
access to psychologists and social workers, so they're aware that they
have a full team of support. That's an area where continous improvement
could be made.
And in terms of advances in cancer treatment, how do those advances impact
these patients, whether it's in the systemic therapy realm or in surgical
techniques. There's a lot of room to grow.
Advertisement
Advertisement
Large-scale database also reveals potential for immunotherapy to protect against cancer
Findings may help guide discussions around prognosis and allogeneic stem cell transplantation
Research underscores the importance of access to timely diagnosis and treatment in this patient population.
A Cleveland Clinic model combining clinical staging, genomics and AI predicts survival with 18% greater accuracy — and could help match patients to more effective treatments.
Study serves as ‘cautionary tale’ for physicians tempted to rely on liquid biopsy results alone
Direct delivery of viral-based vector KB707 to the lungs may boost anti-tumor response and help overcome immune checkpoint inhibitor resistance
Evidence-based recommendations for managing pain, nausea and other treatment reactions
Emerging data and practice changes reduce toxicity burden of treatment